MLM Medical Labs - Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence

February 18, 2025 03:19 AM AEDT | By EIN Presswire
 MLM Medical Labs - Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence
Image source: EIN Presswire
MöNCHENGLADBACH, NORTH RHINE-WESTPHALIA, GERMANY, February 17, 2025 /EINPresswire.com/ -- MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, announced today it has received notice of continued accreditation from the College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists and a leading provider of laboratory accreditation programs, for its laboratory in Mönchengladbach, Germany. The Mönchengladbach facility has been continuously CAP accredited since 2014, marking over a decade of successful accreditation.

During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures to ensure strict adherence to current best practices. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

According to Dr. Stephan Voswinkel, Managing Director MLM Germany, “MLM Medical Labs is committed to delivering the highest quality, clinically actionable information and data to our clients in the clinical trials industry.” Voswinkel added, “CAP accreditation is considered to be the most rigorous choice for lab accreditation, often exceeding the standards of state and federal agencies, and we are honored to have continued to maintain this approval.”

In addition to its CAP-accredited laboratory in Germany, MLM owns two accredited laboratories in the United States—one in Memphis, TN, and another in Minneapolis, MN. Both U.S. laboratories hold either CAP or CLIA accreditation, ensuring the highest standards of quality and compliance in laboratory services. These facilities further strengthen MLM’s ability to provide comprehensive laboratory solutions to clients worldwide.


About MLM Medical Labs
MLM Medical Labs is an international central laboratory with locations in Europe and North America. An international team of more than 200 highly skilled and experienced employees that supports over 300 clinical trials at any given time. MLM offers a broad range of services with an assay portfolio of over 2,000 parameters, including central lab testing, analysis of biomarkers, histology, preclinical services, assay development, kit building, and long-term sample management and storage. The company is headquartered in Mönchengladbach, Germany (near Düsseldorf) and has laboratories in Memphis, TN, and Minneapolis, MN, USA.
For more information, please visit www.mlm-labs.com.

About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.
For more information, visit www.CAP.org.

Michael Howell
MLM Medical Labs
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.